ASO Author Reflections: Neoadjuvant Therapy for Ampullary and Duodenal Adenocarcinoma-What Do We Know?

Ann Surg Oncol. 2024 Feb;31(2):808-809. doi: 10.1245/s10434-023-14625-7. Epub 2023 Nov 22.

Authors

Chunmeng Zhang¹, Bradley N Reames²

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
² Division of Surgical Oncology, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA. bradley.reames@unmc.edu.

PMID: 37993747
DOI: 10.1245/s10434-023-14625-7

No abstract available

Publication types

Comment

MeSH terms

Adenocarcinoma* / therapy
Duodenal Neoplasms* / therapy
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms*